Is HURN a Good Stock to Buy? The Bull and Bear Case (2026)
Last updated November 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Huron Consulting Group Inc. (HURN) rests on Healthcare demand and the shift toward managed services: Healthcare is the largest segment, at ~$232.3M of RBR in Q2 2026, up ~17% year over year, on segment operating income of ~$69.9M. The bear case rests on the central risk is the one the market has repriced repeatedly this year: if generative AI compresses the hours clients will pay for, a business built on utilization and staffing leverage degrades fast, and Huron's consulting utilization near ~81% sits closer to the top of its historical range than the bottom. Analysts covering it publish targets from $215.00 to $220.00 against a $173.07 share price on November 16, 2026, so even the professionals disagree by 2% of their own average. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
HURN key stats
At $173.07 on November 16, 2026, Huron Consulting Group Inc. (HURN) has a market cap of $2.7B and a P/E of 25.9 on trailing earnings (16.3 on forward earnings).
- Market cap
- $2.7B
- P/E (trailing)
- 25.9
- P/E (forward)
- 16.3
- EPS (trailing 12 months)
- $6.67
- Price to book
- 6.5
- Beta
- 0.07
Market cap, P/E and yield are measured at the $173.07 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.
What's new with Huron Consulting Group Inc. (HURN)?
The last two weeks for Huron Consulting Group Inc., as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.
- HURN closed at $173.07 on November 16, 2026, up 7.1% over the past five trading days (from $161.57).
- On November 3, 2026, Huron Consulting Group Inc. filed its quarterly report (10-Q) with the SEC. Read the 10-Q on sec.gov
- On November 3, 2026, Huron Consulting Group Inc. filed an 8-K with the SEC reporting quarterly results (Item 2.02). Read the 8-K on sec.gov
- On November 4, 2026, Wedbush raised its target to $220.00 from $160.00 (Outperform).
Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.
Huron Consulting Group was formed in 2002 by former Arthur Andersen partners and has built itself into a global professional services firm organized around three industry segments. Healthcare produced ~50% of revenues before reimbursable expenses in the first half of 2026, Education ~29%, and Commercial ~21%. The work runs through two capabilities: consulting and managed services covers performance improvement, cost reduction, clinical operations, revenue cycle and research administration, while the digital practice implements and then operates enterprise platforms from Workday, Oracle and Salesforce for the same client base. As of June 30, 2026 Huron employed ~5,335 revenue-generating professionals outside managed services, plus ~3,913 managed services staff, a headcount that more than doubled year over year after the RelateCare acquisition (completed in June) added roughly ~1,100 people in patient access. Buying capability is a standing part of the model, with Eclipse Insights, Treliant and WP&C folded in during 2025. The June 2026 quarter was a record on the company's own numbers: revenues before reimbursable expenses of ~$465.6M, up ~15.7% year over year and ~10.8% excluding acquisitions, adjusted EBITDA of ~$72.6M, adjusted EPS of ~$2.46 against a ~$2.17 consensus, and management raising full-year RBR guidance to a range of ~$1.85B to ~$1.89B. The share price has told a different story. Shares fell to ~$85 at the 52-week low, and the company repurchased stock at an average of ~$97 during June, before the late-July report started a rebound that carried the price to ~$175 by mid-October, close to the ~$187 52-week high and up ~2% for 2026. What moved was the multiple rather than the results, as investors argued over whether generative AI compresses the billable hours consultancies sell. In late September the CFO laid out a target of sustained low-double-digit RBR growth through 2029 and a 15%-17% adjusted EBITDA margin. Leverage moved too. Net debt stood at ~$833M and the consolidated leverage ratio at ~2.8x on June 30, against ~1.9x at the end of 2025, the product of ~$208.6M of buybacks in six months alongside deal spending.
The bull case: what would have to be true for $220.00
The most optimistic published target on HURN is $220.00, +27.1% from the $173.07 share price on November 16, 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Healthcare demand and the shift toward managed services
Healthcare is the largest segment, at ~$232.3M of RBR in Q2 2026, up ~17% year over year, on segment operating income of ~$69.9M. Hospital systems under sustained margin pressure keep buying cost, clinical operations and revenue cycle work, which is the least discretionary part of Huron's portfolio. The RelateCare deal added roughly ~1,100 patient access staff, and management said in September that healthcare managed services grew ~43% early in 2026 and should reach about ~20% of the segment next year on a pro forma basis, at margins broadly in line with the segment.
2. Education, where budget stress is itself the demand driver
Education RBR was ~$139.4M in Q2 2026, up ~7.8%, with segment operating income of ~$37.4M. Universities facing enrollment softness and unsettled federal research funding tend to buy administrative restructuring and ERP modernization, so pressure on the client is what creates the engagement. Growth here is slower than in the other two segments, but Huron is among the largest Workday and Oracle implementers in higher education, and those relationships are difficult for a rival to dislodge mid-program.
3. Digital, and an AI argument that cuts both ways
Digital capability utilization rose to ~81.8% in Q2 2026 from ~77.8% a year earlier, near the upper end of what a staffing-leverage model can sustain. Management describes proprietary industry data combined with AI tooling as a source of differentiation and pricing power, citing uses in financial scenario planning, patient referral intake and payer workflows. The opposing case is that AI erodes the pyramid of billable junior hours that funds firms like this one. Reported results so far are consistent with either reading, which is precisely why the multiple has been unstable, swinging from a low near ~$85 to ~$175 within the year.
4. A share count that keeps shrinking
Huron repurchased ~1.55M shares for ~$208.6M in the first half of 2026, roughly ~9% of the shares outstanding at the end of 2025, leaving ~$92.0M available under the ~$900M authorization at June 30. Diluted shares used in EPS fell to ~16.4M in Q2 2026 from ~17.8M a year earlier, which is a meaningful part of reported per-share growth. The repurchases were funded in part with revolver borrowings, so the EPS arithmetic carries a balance sheet cost; management has said it targets year-end leverage of ~2x to ~2.5x and that 2027 could bring more acquisitions.
The bear case: what would have to be true for $215.00
The most pessimistic published target is $215.00, +24.2% from the current price. It is neither a floor nor a forecast; it is roughly what one analyst thinks Huron Consulting Group Inc. is worth if the risks below bite instead of the drivers above.
The central risk is the one the market has repriced repeatedly this year: if generative AI compresses the hours clients will pay for, a business built on utilization and staffing leverage degrades fast, and Huron's consulting utilization near ~81% sits closer to the top of its historical range than the bottom. After a ~58% three-month rally, the stock also has less valuation cushion than it did in the spring. Leverage climbed sharply in the first half, to a consolidated leverage ratio of ~2.8x against a ~3.75x covenant limit, which narrows the room for both further buybacks and further acquisitions. The balance sheet carries ~$805M of net goodwill after ~$456M of accumulated impairments from earlier deals, so this is a company that has written down acquisitions before. Education revenue is exposed to university budgets and federal research funding, neither of which is settled. In the Form 10-Q for the quarter ended June 30, 2026, Huron stated it is not party to any litigation management expects to have a material adverse effect, and no securities class action is disclosed.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding HURN already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on HURN
4 analysts cover HURN, with an average target of $218.00 (+26.0% against $173.07) and a split of 5 buy, 0 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the HURN forecast and price target page.
How is HURN valued?
Market cap, P/E and dividend yield at today's price are in the HURN key stats above. The business figures below come from Huron Consulting Group Inc.'s reported results as of October 2026 and change when it next reports.
- Revenue (TTM, before reimbursable expenses): ~$1.77B
- Revenue growth (Q2 2026, YoY): ~15.7%
- Operating / net margin (TTM): ~11.7% / ~6.5%
- 2026 RBR guidance: ~$1.85B to ~$1.89B
- Total debt / cash: ~$865M / ~$32M
As of October 2026: At roughly ~$175 a share, Huron carries a market capitalization near ~$2.8B, about ~19x the ~$9.20 midpoint of 2026 adjusted EPS guidance and ~16.5x the ~$10.59 analysts expect for 2027, a full step up from the ~16x it traded at on 2026 guidance in August. EV/EBITDA is about ~14x. Trailing GAAP earnings look weaker than the adjusted figures because of intangible amortization, transaction costs and investment write-downs, and the gap between the two is wide enough to be worth re-checking each quarter. Q3 consensus for the November 3 report is ~$2.47 of EPS on ~$481M of revenue.
How do you decide if HURN is a buy?
Whether HURN is a buy is easier to judge through four narrower questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold HURN indirectly through an index or sector ETF before adding more.
What would change your mind on HURN
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Healthcare demand and the shift toward managed services stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
- Bear case breaks if: the central risk is the one the market has repriced repeatedly this year: if generative AI compresses the hours clients will pay for, a business built on utilization and staffing leverage degrades fast, and Huron's consulting utilization near ~81% sits closer to the top of its historical range than the bottom fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the HURN stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about HURN against your real portfolio and see your actual exposure before deciding.
Your questions about Huron Consulting Group Inc.
Ask Walnut's AI anything about HURN and see how it fits what you own.
FAQ
Is HURN a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Healthcare demand and the shift toward managed services, with revenue (ttm, before reimbursable expenses) at ~$1.77B. The bear case rests on the central risk is the one the market has repriced repeatedly this year: if generative AI compresses the hours clients will pay for, a business built on utilization and staffing leverage degrades fast, and Huron's consulting utilization near ~81% sits closer to the top of its historical range than the bottom. Analysts covering it are spread from $215.00 to $220.00, a spread wide enough to show the question is contested. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.
Should I sell HURN?
+
Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The central risk is the one the market has repriced repeatedly this year: if generative AI compresses the hours clients will pay for, a business built on utilization and staffing leverage degrades fast, and Huron's consulting utilization near ~81% sits closer to the top of its historical range than the bottom. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. The most pessimistic published target is $215.00, +24.2% from the $173.07 price, which is one analyst's downside case. It is not a floor. Walnut is not an investment adviser.
What is the bull case for HURN?
+
Healthcare demand and the shift toward managed services. Healthcare is the largest segment, at ~$232.3M of RBR in Q2 2026, up ~17% year over year, on segment operating income of ~$69.9M. The most optimistic analyst target on HURN is $220.00, +27.1% from the $173.07 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for HURN?
+
The central risk is the one the market has repriced repeatedly this year: if generative AI compresses the hours clients will pay for, a business built on utilization and staffing leverage degrades fast, and Huron's consulting utilization near ~81% sits closer to the top of its historical range than the bottom. After a ~58% three-month rally, the stock also has less valuation cushion than it did in the spring. Leverage climbed sharply in the first half, to a consolidated leverage ratio of ~2.8x against a ~3.75x covenant limit, which narrows the room for both further buybacks and further acquisitions. The balance sheet carries ~$805M of net goodwill after ~$456M of accumulated impairments from earlier deals, so this is a company that has written down acquisitions before. Education revenue is exposed to university budgets and federal research funding, neither of which is settled. In the Form 10-Q for the quarter ended June 30, 2026, Huron stated it is not party to any litigation management expects to have a material adverse effect, and no securities class action is disclosed. The most pessimistic published target is $215.00, +24.2% from the current price, which is roughly what one analyst thinks the stock is worth if these risks bite and the drivers do not.
What does Huron Consulting Group Inc. do?
+
Global professional services firm providing consulting, digital and managed services to healthcare systems, universities and commercial clients.
What would have to change for HURN to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Healthcare demand and the shift toward managed services) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (the central risk is the one the market has repriced repeatedly this year: if generative AI compresses the hours clients will pay for, a business built on utilization and staffing leverage degrades fast, and Huron's consulting utilization near ~81% sits closer to the top of its historical range than the bottom) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does Huron Consulting Group do?
+
Huron is a professional services firm that advises and operates for clients in three industries: healthcare, education and commercial. Services span cost and performance improvement, clinical and revenue cycle operations, research administration, regulatory and financial services consulting, and the implementation and ongoing operation of enterprise software from Workday, Oracle and Salesforce.
How big is each Huron segment?
+
For the first half of 2026, Healthcare was ~50% of revenues before reimbursable expenses, Education ~29% and Commercial ~21%. In the June 2026 quarter, Healthcare RBR was ~$232.3M, Education ~$139.4M and Commercial ~$94.0M, with segment operating income of ~$69.9M, ~$37.4M and ~$19.8M respectively.
Why did HURN stock fall so far in 2026?
+
The decline tracked sentiment on AI rather than reported results. Shares dropped sharply after the May 2026 first quarter report despite record revenue and reaffirmed guidance, as investors questioned whether generative AI erodes the billable-hours model across consulting. The stock traded as low as ~$85, then recovered after the July 2026 second quarter beat and guidance raise, reaching ~$175 by October 16, 2026, roughly ~2% above where it started the year.
Walnut is informational, not investment advice, and gives no verdict on HURN. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. The share price is the last one Yahoo Finance reported on November 16, 2026. Verify current figures with your broker before acting on them.